These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28949445)

  • 1. Impact of selective anti-BMP9 treatment on tumor cells and tumor angiogenesis.
    Brand V; Lehmann C; Umkehrer C; Bissinger S; Thier M; de Wouters M; Raemsch R; Jucknischke U; Haas A; Breuer S; Birzele F; Racek T; Reis M; Lorenzon E; Herting F; Stürzl M; Lorenz S; Kienast Y
    Mol Oncol; 2016 Dec; 10(10):1603-1620. PubMed ID: 28949445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
    Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L
    PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.
    Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S
    J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sinomenine hydrochloride attenuates the proliferation, migration, invasiveness, angiogenesis and epithelial-mesenchymal transition of clear-cell renal cell carcinoma cells via targeting Smad in vitro.
    Zhao B; Liu L; Mao J; Liu K; Fan W; Liu J; Zhang Z; Li Q
    Biomed Pharmacother; 2017 Dec; 96():1036-1044. PubMed ID: 29198924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study.
    Shi CS; Kuo KL; Chen MS; Chow PM; Liu SH; Chang YW; Lin WC; Liao SM; Hsu CH; Hsu FS; Chang HC; Huang KH
    Cells; 2019 Nov; 8(11):. PubMed ID: 31752390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP9 counteracts the tumorigenic and pro-angiogenic potential of glioblastoma.
    Porcù E; Maule F; Boso D; Rampazzo E; Barbieri V; Zuccolotto G; Rosato A; Frasson C; Viola G; Della Puppa A; Basso G; Persano L
    Cell Death Differ; 2018 Nov; 25(10):1808-1822. PubMed ID: 29977042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability.
    Akla N; Viallard C; Popovic N; Lora Gil C; Sapieha P; Larrivée B
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1821-1836. PubMed ID: 29880487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoglin requirement for BMP9 signaling in endothelial cells reveals new mechanism of action for selective anti-endoglin antibodies.
    Nolan-Stevaux O; Zhong W; Culp S; Shaffer K; Hoover J; Wickramasinghe D; Ruefli-Brasse A
    PLoS One; 2012; 7(12):e50920. PubMed ID: 23300529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides.
    Margheri F; Schiavone N; Papucci L; Magnelli L; Serratì S; Chillà A; Laurenzana A; Bianchini F; Calorini L; Torre E; Dotor J; Feijoo E; Fibbi G; Del Rosso M
    PLoS One; 2012; 7(11):e50342. PubMed ID: 23226264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEMA3G regulates BMP9 inhibition of VEGF-mediated migration and network formation in pulmonary endothelial cells.
    Mirza SL; Upton PD; Hodgson J; Gräf S; Morrell NW; Dunmore BJ
    Vascul Pharmacol; 2024 Jun; 155():107381. PubMed ID: 38795838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology.
    Ruiz S; Chandakkar P; Zhao H; Papoin J; Chatterjee PK; Christen E; Metz CN; Blanc L; Campagne F; Marambaud P
    Hum Mol Genet; 2017 Dec; 26(24):4786-4798. PubMed ID: 28973643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas.
    Dumond A; Montemagno C; Vial V; Grépin R; Pagès G
    Cells; 2021 May; 10(5):. PubMed ID: 34067671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains.
    Kienast Y; Jucknischke U; Scheiblich S; Thier M; de Wouters M; Haas A; Lehmann C; Brand V; Bernicke D; Honold K; Lorenz S
    J Biol Chem; 2016 Feb; 291(7):3395-410. PubMed ID: 26677222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
    Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
    Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP9 signaling promotes the normalization of tumor blood vessels.
    Viallard C; Audiger C; Popovic N; Akla N; Lanthier K; Legault-Navarrete I; Melichar H; Costantino S; Lesage S; Larrivée B
    Oncogene; 2020 Apr; 39(14):2996-3014. PubMed ID: 32042114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.
    Ricard N; Ciais D; Levet S; Subileau M; Mallet C; Zimmers TA; Lee SJ; Bidart M; Feige JJ; Bailly S
    Blood; 2012 Jun; 119(25):6162-71. PubMed ID: 22566602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP9 Induces Cord Blood-Derived Endothelial Progenitor Cell Differentiation and Ischemic Neovascularization via ALK1.
    Kim J; Kim M; Jeong Y; Lee WB; Park H; Kwon JY; Kim YM; Hwang D; Kwon YG
    Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):2020-31. PubMed ID: 26229139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex.
    Townson SA; Martinez-Hackert E; Greppi C; Lowden P; Sako D; Liu J; Ucran JA; Liharska K; Underwood KW; Seehra J; Kumar R; Grinberg AV
    J Biol Chem; 2012 Aug; 287(33):27313-25. PubMed ID: 22718755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
    Jeong DE; Song HJ; Lim S; Lee SJ; Lim JE; Nam DH; Joo KM; Jeong BC; Jeon SS; Choi HY; Lee HW
    Oncotarget; 2015 Oct; 6(32):33046-64. PubMed ID: 26426994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting olfactomedin-like 3 inhibits tumor growth by impairing angiogenesis and pericyte coverage.
    Miljkovic-Licina M; Hammel P; Garrido-Urbani S; Lee BP; Meguenani M; Chaabane C; Bochaton-Piallat ML; Imhof BA
    Mol Cancer Ther; 2012 Dec; 11(12):2588-99. PubMed ID: 23002094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.